Table 3. Efficacy end points (as treated analysis).

End points	Caphosol plus SC (n = 103)		Standard care (SC) (n = 107)		p value
	No.	%	No.	%
Primary
Incidence of ≥G3 OM	66	64.1	70	65.4	0.839
Secondary
Duration of ≥G3 OM (days)
Mean (SD)	16.8 (17.5)		17.5 (21.9)		0.692
Incidence of ≥G3 PM	59	57.3	68	64.2	0.309
Duration of ≥G3 PM (days)
Mean (SD)	13.7 (16.7)		18.4 (21.5)		0.187
Incidence of ≥G3 PD	30	29.1	33	31.1	0.752
Duration of ≥G3 PD (days)
Mean (SD)	8.3 (16.7)		9.7 (19.5)		0.671
Incidence of ≥G3 pain	50	48.5	58	54.7	0.372
Duration of ≥G3 pain
Mean (SD)	18 (24.7)		20 (24.1)		0.397

OM – oral mucositis, PM – pharyngeal mucositis, PD – pharyngeal dysphagia